Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization

Niklas Zojer, Robert Königsberg, Jutta Ackermann, +11

Blood

Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy

Johannes Drach, Jutta Ackermann, E. Fritz, +10

Blood

Adriamycin cardiotoxicity: a survey of 1273 patients.

C Praga, G. Beretta, Vigo Pl, +20

PubMed

Ecg MonitoringHeart FailureOncologyMedicineAdriamycin Cardiotoxicity +11

Ki-1-Positive Large Cell Lymphoma

Andreas Chott, Klaus Kaserer, Ingrid Augustin, +5

The American Journal of Surgical Pathology

Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization.

Johannes Drach, J. C. Schuster, H. Nowotny, +7

PubMed

CytogeneticsChromosomal AneuploidyGeneticsMixed-phenotype Acute LeukemiaPathology +14

Predictive Role of Interphase Cytogenetics for Survival of Patients With Multiple Myeloma

Robert Königsberg, Niklas Zojer, Jutta Ackermann, +13

Journal of Clinical Oncology

[Necrobiotic xanthogranuloma in paraproteinemia].

Klemens Rappersberger, Friedrich Wrba, R. Heinz, +2

PubMed

Granulocyte Colony-Stimulating Factor as an Adjunct to Induction Chemotherapy for Adult Acute Lymphoblastic Leukemia — A Randomized Phase-III Study

Elisabeth Koller, Eva Hubmann, Dietger Niederwieser, +11

Blood

Cross‐validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics

Michael Pfeilstöcker, Regina Reisner, Thomas Nösslinger, +6

British Journal of Haematology

Mixed-phenotype Acute LeukemiaPrognosisDiagnosisPathologyMyeloid Neoplasia +14

Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group.

Brigitte Schlegelberger, Thomas Zwingers, Lana Harder, +11

PubMed